Matching slides 1,369
Current window 841-870
Pages 46
Rows per page 30
Framework: Antagonist Introductionclear collectionreset all

Framework

841-870 of 1,369

filter-aware
283
The slide uses direct quotes from a KOL to build a case against the safety profile of the drug.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
299
The slide uses direct Q&A transcripts to highlight the investigator's negative sentiment and concerns about patient safety (diabetes/hyperglycemia).Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
331
The slide uses direct quotes from an endocrinologist/KOL to undermine the clinical trial results.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
332
The slide uses a direct quote from an endocrinologist to undermine the primary endpoint of a clinical trial.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
357
The slide uses a 'villain' narrative by framing a specific researcher (Jennifer Miller) and patient families as a 'cult' driving artificial demand.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
389
The slide uses a Q&A format to highlight expert skepticism regarding the drug's necessity and cost-effectiveness.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
45
The slide uses highly charged, competitive language ('catastrophic', 'game over', 'will disappear') to frame the competitive threat.Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Beat · The Victory1 hit
03
The slide uses anecdotal evidence to frame the company's leadership as a 'villain' figure, specifically highlighting potential legal and regulatory scrutiny.TransMedics (TMDX) · Scorpion Capital
Research note Short seller Beat · Testimonials from Industry Experts1 hit
11
The slide uses extreme, inflammatory language to attack the subject company and its leadership.TransMedics (TMDX) · Scorpion Capital
Research note Short seller Beat · Critique of TransMedics Group Inc.1 hit
12
The slide uses a 'Spy The Lie' framework to interpret CEO responses as deceptive.TransMedics (TMDX) · Scorpion Capital
Research note Short seller Beat · Critique of TransMedics Group Inc.1 hit
20
The slide uses strong, emotive language ('greedy', 'predatory', 'hate') to frame the company as a villain in the transplant market.TransMedics (TMDX) · Scorpion Capital
Research note Short seller Beat · Critique of TransMedics Group Inc.1 hit
21
The slide uses a combination of narrative analysis and direct testimonial quotes to build a bearish case against the company.TransMedics (TMDX) · Scorpion Capital
Research note Short seller Beat · Exposure of Contradictions1 hit
24
The slide uses a 'villain' framing to attack the company's business model as exploitative of the US healthcare system.TransMedics (TMDX) · Scorpion Capital
Research note Short seller Beat · Exposure of Contradictions1 hit
27
The slide uses a combination of investigative journalism style text and corporate marketing materials to expose a perceived conflict of interest.TransMedics (TMDX) · Scorpion Capital
Research note Short seller Beat · Exposure of Contradictions1 hit
60
The slide uses direct quotes to build a case for anticompetitive behavior, specifically focusing on the forced bundling of procurement services with product usage.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
69
The slide uses Q&A format to build a narrative of unethical behavior and coercion.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
132
The slide uses a 'villain' narrative framing, comparing the medical system to a cartel and highlighting the 'addiction to volume' as a driver for TransMedics service adoption.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
137
The slide uses a Q&A format to highlight a specific allegation of unethical business practices.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
139
The slide uses a Q&A format to present testimonial evidence of alleged misconduct.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
145
The slide uses a Q&A format to present testimony from an industry veteran, highlighting allegations of unethical sales practices.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
154
Includes a direct quote from an unnamed source regarding the company's technicians.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
198
The slide uses a Q&A format to present a negative expert opinion on TransMedics' clinical quality and hiring standards.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
202
The slide uses direct quotes to highlight negative perceptions of TransMedics' hiring practices and surgeon qualifications.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
204
The slide uses direct quotes to frame the subject as a villain/incompetent actor. It is a classic 'expert testimony' attack.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
228
The slide uses a Q&A format to highlight alleged unethical practices regarding organ safety and corporate pressure.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
241
The slide uses a quote from Congressman Paul Gosar to substantiate claims of a 'bait and switch' business model.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
248
The slide uses a Q&A transcript format to substantiate claims of poor management and safety negligence.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
250
The slide uses strong, emotive language to frame the company's leadership as the primary antagonist.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
288
The slide uses a 'before-after' style comparison between a conceptual timeline and actual competitor hardware.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
306
The slide uses a 'villain' narrative structure to frame TransMedics as vulnerable to upcoming competition.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit